Learn About Convertible Debt Financing
In this webinar, you’ll learn when to consider a convertible debt financing, the role of the convertible debt term sheet in the financing process, key terms and negotiation points, practical tips and considerations to help advance your financing, and how convertible debt financing terms affect your cap table.
Presented by Carlos Heredia
Startup Attorney (Stanford JD/MBA)
Carlos works closely with startups and growing companies across a variety of technologies and industries, advising them on legal and business matters at early-stage startup, funding and sale. As a startup attorney, he has seen many business plans, approaches and decisions, many done well and many done wrong. Carlos takes a practical legal approach with his clients and is dedicated to making a tangible difference and positive impact on their businesses, knowing firsthand the challenges of not only launching a startup, but also managing a successful business and planning for the future.
Presented byMatt Steiner
Startup Attorney
Matt has a gift for finding thoughtful and creative solutions while structuring transformational deals and loves working on venture financings and M&A transactions. He also enjoys being in the trenches, advising and supporting clients on their most important matters.
Matt is a business lawyer and advisor focused on representing entrepreneurs, startups and established businesses. His practice consists of working with entrepreneurs from idea to exit, angel and venture capital financing transactions, mergers and acquisitions and acting as outside general counsel to startups and emerging growth companies.
Presented byJamie Norrdin
Startup Attorney
Jamie has extensive experience assisting startups and growing companies with various business and corporate matters, including entity formation, debt and equity financings, mergers and acquisitions and corporate governance. Jamie also focuses on a wide range of corporate and commercial transactions, including strategic alliances and joint ventures, technology licensing and acquisitions, clinical research and life science transactions, as well as manufacturing, supply and distribution relationships.
